Clinical Review
2017 Update on female sexual dysfunction
New and emerging treatment options hold promise for improving outcomes in this undertreated disorder
Expert Commentary
Hypoactive sexual desire disorder: The ideal patient for treatment with flibanserin
Recommended Reading
Related Articles
-
-
Clinical Review
2016 Update on female sexual dysfunction
With many, and growing, options for managing the sexual health of your patients, how would these 5 experts manage the following common case...
-
News
What you need to know (and do) to prescribe the new drug flibanserin
11 questions and answers highlight indications, risks, adverse reactions, and requirements for prescribers
-
Expert Commentary
Flibanserin is poised for FDA approval. But why this drug? And why now?
Women with hypoactive sexual desire disorder have long sought a remedy for this common complaint. With an advisory committee recommending approval...
